Aldesleukin Recruiting Phase 1 Trials for Clear Cell Renal Cell Carcinoma / Stage IV Renal Cell Cancer / Stage III Renal Cell Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03260504Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer